Bionik Laboratories Corp Stock Analysis
Bionik Laboratories Corp is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Bionik Laboratories pink sheet analysis is to determine its intrinsic value, which is an estimate of what Bionik Laboratories Corp is worth, separate from its market price. There are two main types of Bionik Laboratories' stock analysis: fundamental analysis and technical analysis.
The Bionik Laboratories pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Bionik |
Bionik Pink Sheet Analysis Notes
About 62.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.78. Bionik Laboratories Corp last dividend was issued on the 30th of October 2018. The entity had 1:150 split on the 30th of October 2018. Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts. BIONIK LABORATORIES operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 12 people.The quote for Bionik Laboratories Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bionik Laboratories Corp please contact CPA Russo at 617 926 4800 or go to https://www.bioniklabs.com.Bionik Laboratories Corp Investment Alerts
| Bionik Laboratories generated a negative expected return over the last 90 days | |
| Bionik Laboratories has high historical volatility and very poor performance | |
| Bionik Laboratories has some characteristics of a very speculative penny stock | |
| Bionik Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (10.41 M) with profit before overhead, payroll, taxes, and interest of 953.26 K. | |
| Bionik Laboratories Corp currently holds about 1.33 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Roughly 62.0% of the company shares are held by company insiders |
Bionik Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.27 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bionik Laboratories's market, we take the total number of its shares issued and multiply it by Bionik Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Bionik Laboratories Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bionik Laboratories Corp Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bionik Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bionik Laboratories Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bionik Laboratories Outstanding Bonds
Bionik Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bionik Laboratories Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bionik bonds can be classified according to their maturity, which is the date when Bionik Laboratories Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
About Bionik Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Bionik Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bionik shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Bionik Laboratories. By using and applying Bionik Pink Sheet analysis, traders can create a robust methodology for identifying Bionik entry and exit points for their positions.
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts. BIONIK LABORATORIES operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 12 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Bionik Laboratories to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Other Information on Investing in Bionik Pink Sheet
Bionik Laboratories financial ratios help investors to determine whether Bionik Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bionik with respect to the benefits of owning Bionik Laboratories security.